Superb Microvascular Imaging in Focal Nodular Hyperplasia
Focal Nodular Hyperplasia
About this trial
This is an interventional diagnostic trial for Focal Nodular Hyperplasia focused on measuring Focal nodular hyperplasia, Ultrasonography, Superb-Microvascular imaging, Contrast-enhanced ultrasonography
Eligibility Criteria
Inclusion Criteria:
1. Patients with biopsy or imaging proven focal nodular hyperplasia
Exclusion Criteria:
- Pregnant women
- Patient's age > 70
- Egg allergy
- Breast-feeding women
Sites / Locations
- Samsung Medical Center
Arms of the Study
Arm 1
Experimental
SMI and sonazoid (single arm)
Patients with focal nodular hyperplasia will undergo ultrasonography with Superb-Microvascular imaging and additional sonazoid-enhanced ultrasonography. SMI is a software function in a Toshiba Aplio 500 system. Sonazoid is contrast-material for US and it is a intervention for patient with FNH. Sonazoid will be administered at a dose of 0.015 mL/kg by manual bolus injection, followed by a 10 mL normal saline flush via a peripheral venous line